Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis (Q81211630)
Jump to navigation
Jump to search
scientific article published on 01 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis |
scientific article published on 01 November 2004 |
Statements
Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis (English)
Alice B Gottlieb
Kenneth B Gordon
Mark G Lebwohl
Ivor Caro
Patricia A Walicke
Nicole Li
Craig L Leonardi
EFALIZUMAB STUDY GROUP
1 November 2004